Activates integrin-linked kinase (ILK) → improves cell adhesion and motility.
Reduces pro-inflammatory cytokines and upregulates protective pathways.
BPC-157:
Upregulates angiogenic growth factors such as VEGF, facilitating neovascularization and enhanced blood flow to damaged tissues.
Modulates the nitric oxide (NO) system, improving endothelial function and promoting vasodilation.
Influences the expression of genes involved in inflammatory regulation and tissue regeneration and supports collagen synthesis through activation of fibroblasts. Exerts cytoprotective effects on epithelial and endothelial cells.
More Information
Disclaimer: For Research Purposes Only – All products on this site are for Research and Development use only. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Celia Health is a supplier of research-use chemicals manufactured in a CGMP facility in the US. Celia Health is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act.